Page 113 - Screening for Cervical Cancer: Systematic Evidence Review

Appendix C. Evidence Tables

Evidence Table 1A. Screening Among Older Women (cont'd)

Screening Outcomes & Quality
Participants Program Measures Relevant Results Considerations
N = 128,805 Primary AGE: Denom=2
women with outcome = Incidence of abnormalities within 36 Attrition=2
initial normal HSIL+ on month following 1, 2, or 3 Indications=1
Pap and at cytology consecutive normal smears Interval=2
least another in LSIL HSIL+ Age=2
the timeframe % % Relevance=2
<30 (1) 3.47 0.65 Standard=0
Mean age = (2) 2.33 0.67 Score=11
49.9 13.3 yrs (3) 1.70 0.62
30-39 1.48 0.44 Grade=Fair
0.90 0.11
0.40 0.11
40-49 0.85 0.18
0.75 0.16
0.40 0.02
50-59 0.49 0.19
0.31 0.10
0.22 0.06
≥ 60 0.35 0.12
0.30 0.09
0.14 0.02

PRIOR HISTORY:
Age& interval adjusted relative risk
#prior normals RR/1,000 (95%CI)
women
1 23.6
2 16.5 (12.0-22.4)
3+ 7.6 (4.0-14.2)

C-19